Chemical compounds and pharmaceutical compositions as cathepsin S inhibitors

Details for Australian Patent Application No. 2002305790 (hide)

Owner Axys Pharmaceuticals, Inc. Aventis Pharmaceuticals Inc.

Inventors Timm, Andreas, P.; Link, John, O.; Thurairatnam, Sukanthini; Li, Jiayao; Zipfel, Sheila; Aldous, David, J.; Graupe, Michael

Agent Watermark

Pub. Number AU-B-2002305790

PCT Number PCT/US02/17411

PCT Pub. Number WO2002/098850

Priority 60/295,301 01.06.01 US

Filing date 3 June 2002

Wipo publication date 16 December 2002

Acceptance publication date 31 January 2008

International Classifications

C07D 295/18 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/277 (2006.01)

A61K 31/341 (2006.01) - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61K 31/351 (2006.01) - not condensed with another ring

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/397 (2006.01) - having four-membered rings, e.g. azetidine

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/423 (2006.01) - condensed with carbocyclic rings

A61K 31/4245 (2006.01) - Oxadiazoles

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/428 (2006.01) - condensed with carbocyclic rings

A61K 31/437 (2006.01)

A61K 31/4453 (2006.01) - only substituted in position 1, e.g. propipocaine, diperodon

A61K 31/4468 (2006.01) - having a nitrogen atom directly attached in position 4, e.g. clebopride, fentanyl

A61K 31/454 (2006.01)

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/5375 (2006.01) - 1,4-Oxazines, e.g. morpholine

A61K 31/5377 (2006.01)

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 1/02 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 13/12 Drugs for disorders of the urinary system

Event Publications

19 December 2002 Complete Application Filed

  Priority application(s): 60/295,301 01.06.01 US

8 May 2003 Application Open to Public Inspection

  Published as AU-B-2002305790

31 January 2008 Application Accepted

  Published as AU-B-2002305790

29 May 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002305791-ARTICLE FOR DEIONIZATION OF WATER

2002305789-METHOD FOR DETECTING TRANSCRIPTION FACTOR-PROTEIN INTERACTIONS